Serological proteomic profiling uncovered CDK5RAP2 as a novel marker in benign prostatic hyperplasia
Our comprehensive analysis systematically explored BPH serum characteristics, proteomic profiles, and identified novel serum markers that may contribute to the understanding of BPH and facilitate early diagnosis and intervention.
Authors
- Yunbao Pan (ORCID: https://orcid.org/0000-0002-6311-2945)
- Huan Xie
- Lili Chen (ORCID: https://orcid.org/0009-0009-1960-4158)
- Xinran Li (ORCID: https://orcid.org/0000-0001-8988-7223)
- Yirong Li (ORCID: https://orcid.org/0000-0002-7493-045X)
- Junli Fan
- Jiajun Wang
- Tao Liu (ORCID: https://orcid.org/0000-0001-9529-6550)
Institutions
- Wuhan University of Technology (CN)
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
Publication Details
- Journal
- Clinical Biochemistry
- Published
- 2024-12-17
- DOI
- https://doi.org/10.1016/j.clinbiochem.2024.110867
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26